Novartis
European stocks fall despite Nvidia gains as Jackson Hole looms
Euro Stoxx 50, FTSE 100 and SMI decline after Nvidia's strong outlook fails to lift broader European equities. Tech sector buoys gains while defensive stocks weigh on Swiss index.
Swiss equities drift as oil rises, Fed rate bets firm
SMI slips 0.24% as Brent crude tops $91/bbl on Middle East strikes; Holcim leads SMI laggards while Gurit, Kühne+Nagel gain. UBS faces regulatory scrutiny.
Swiss Market Index edges lower as heavyweights weigh amid oil spike
SMI slips 0.24% in narrow trading; Kühne+Nagel leads gains while Holcim, ABB lag. Brent crude rises 3.3% to $90.98 as Middle East tensions escalate.
Swiss Market Index shifts to 40% pharma weight after latest rebalancing
Healthcare now dominates the SMI after recent additions, raising concentration concerns but offering diversification within the sector itself.
Swiss Market Index rises 0.54% as ABB, Swisscom lead gains; Amrize hits record low
The SMI advanced to 14,525 points, supported by eurozone data and falling oil prices, while Amrize tumbled to an all-time low after another CFO departure. Swisscom, ABB and Sika led sector gains.
Swiss SMI edges up 0.12% as Roche, Novartis weigh on blue chips
Amrize and Holcim lead gains in the SMI, while Stadler Rail surges 22% on strong half-year results. US PCE inflation ticks up to 3.7%, lifting September Fed hike odds to 40%.
Swiss stocks rise as SMI nears record; Roche, Novartis lag; U.S. futures mixed
Swiss Market Index climbs 0.5% as construction shares lead gains; SAP downgraded by UBS despite raised price target. U.S. futures diverge ahead of Nvidia earnings and key data.
Nvidia lifts U.S. tech futures ahead of Wall Street open; SMI slips on heavyweights
Nvidia’s strong outlook drove semiconductor stocks higher in premarket trading, while Swiss blue chips fell as Nestlé, Novartis and Roche weighed on the SMI. Focus shifts to Jackson Hole Fed symposium.
Swiss stocks fall 1.1% as heavyweights weigh; Partners Group leads gains
Defensive Swiss equities lagged as the SMI slipped 1.1% to 14,384 amid profit-taking ahead of Jackson Hole. Partners Group surged 2.2% while Nestlé, Novartis and Roche declined.
Nvidia lifts premarket U.S. stocks; Swiss Market Index falls on heavyweights
Nvidia shares rose 5.9% in premarket trading after earnings, lifting Nasdaq futures 1% and S&P 500 futures 0.44%. Swiss Market Index fell 0.9% as Nestlé, Novartis and Roche weighed on the benchmark.
Swiss SMI dips 1% as Nestlé, Novartis, Roche weigh; Gurit surges 10%
Heavyweights drag Switzerland’s blue-chip index lower while Gurit jumps on strong earnings. Investors eye Jackson Hole for Fed clues amid elevated inflation and geopolitical risks.
Swiss SMI falls 0.8% as Nestlé, Novartis, Roche weigh; Gurit jumps 10%
Defensive heavyweights drag Switzerland's blue-chip index lower while chip-linked stocks rise on Nvidia earnings. Brent and WTI oil prices drop over 6% in a week amid Hormuz Strait talks.
Swiss SMI gains 0.5% as construction, tech stocks lead gains
SMI advances toward record high as Amrize, Holcim and Stadler Rail surge; Roche and Novartis weigh on index. Nvidia earnings awaited after U.S. and Asian gains.
Swiss stocks end flat as ABB, pharma weigh; UBS, Vetropack rise
The SMI slipped 0.07% to 14,447 as investors took profits on ABB and sold off Roche and Novartis. UBS gained 1.7% and Vetropack surged 4.4% on company-specific news.
Swiss equities slip as SMI lags; Roche, Novartis weigh; Richemont gains
Swiss benchmark SMI falls 0.25% to 14,423 as Roche and Novartis slide, while Richemont leads gains. US futures point to a softer open after a mixed week.
Eli Lilly's weight-loss pill Foundayo launches in UK, priced at £100-120
The oral GLP-1 treatment, orforglipron, is the second weight-loss pill in the UK after Novo Nordisk's Wegovy. It is available via private prescription while awaiting NHS and EU assessments.
Swiss stocks slip as pharma giants weigh; Nestlé rises, biotech drags
SMI falls 0.25% to 14,423 as Roche and Novartis decline; Nestlé gains 0.5%. Biotech sector under pressure amid broader market caution ahead of key U.S. events.
Swiss market falls as Roche, Novartis weigh; Nestlé, Holcim rise
SMI slips 0.15% as pharma majors drag; Nestlé gains 0.5% while biotech stocks retreat. Brent oil drops 1.5% to $92.94 amid geopolitical jitters.
Swiss market opens lower as pharma stocks weigh; gold hits 3-month high
SMI falls 0.22% in pre-market as Roche and Novartis drag; DAX seen little changed. Brent oil dips 1.5% to $92.94/barrel; WTI at $85.61. Gold climbs 0.75% to $4,637/oz.
SMI rebounds to close higher on strong pharma, cyclical stocks
Swiss benchmark rises 0.62% after midday reversal led by Roche and Novartis; broader gains in materials and industrials offset early losses. Brent crude remains above $94 a barrel amid Middle East tensions.
Swiss stocks edge higher as Roche, Novartis offset losses; Logitech slides
SMI gains 0.1% as healthcare giants support index; Logitech drops 1.3% after JP Morgan downgrade. Oil holds near $92, gold dips as yields fall.
Swiss equities edge higher as Roche, Novartis offset Logitech decline
SMI advances 0.1% on pharma strength; Centiel surges 18% after analyst upgrade. Oil holds near $92/bbl as geopolitical risks persist.
Swiss SMI rebounds into positive territory after midday losses
The SMI turned positive by 0.15% after trading lower all day, with Roche and Novartis narrowing declines. Brent crude held above $93 a barrel amid Middle East tensions.
Swiss SMI posts second straight weekly loss as pharma, Partners Group slide
The Swiss Market Index falls 0.34% to 14,319.29 as Roche, Novartis and Partners Group weigh on blue chips. Brent crude holds above $93 a barrel amid Middle East tensions.